The stock of Merck & Co Inc (MRK) has gone down by -2.81% for the week, with a -0.12% drop in the past month and a 0.87% rise in the past quarter. The volatility ratio for the week is 1.55%, and the volatility levels for the past 30 days are 1.48% for MRK. The simple moving average for the last 20 days is 0.14% for MRK’s stock, with a simple moving average of 12.27% for the last 200 days.
Is It Worth Investing in Merck & Co Inc (NYSE: MRK) Right Now?
Merck & Co Inc (NYSE: MRK) has a higher price-to-earnings ratio of 141.95x compared to its average ratio, The 36-month beta value for MRK is at 0.42. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 4 rating it as “overweight,” 10 as “hold,” and 0 as “sell.”
The public float for MRK is 2.53B, and currently, shorts hold a 0.81% of that float. The average trading volume for MRK on May 06, 2024 was 8.21M shares.
MRK) stock’s latest price update
Merck & Co Inc (NYSE: MRK) has experienced a decline in its stock price by -0.58 compared to its previous closing price of 128.26. However, the company has seen a fall of -2.81% in its stock price over the last five trading days. Zacks Investment Research reported 2024-05-03 that The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here’s why you should take advantage.
Analysts’ Opinion of MRK
Many brokerage firms have already submitted their reports for MRK stocks, with Societe Generale repeating the rating for MRK by listing it as a “Sell.” The predicted price for MRK in the upcoming period, according to Societe Generale is $104 based on the research report published on March 11, 2024 of the current year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see MRK reach a price target of $135, previously predicting the price at $125. The rating they have provided for MRK stocks is “Outperform” according to the report published on January 04th, 2024.
Deutsche Bank gave a rating of “Buy” to MRK, setting the target price at $115 in the report published on November 09th of the previous year.
MRK Trading at 0.85% from the 50-Day Moving Average
After a stumble in the market that brought MRK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.20% of loss for the given period.
Volatility was left at 1.48%, however, over the last 30 days, the volatility rate increased by 1.55%, as shares sank -0.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.35% lower at present.
During the last 5 trading sessions, MRK fell by -2.81%, which changed the moving average for the period of 200-days by +20.35% in comparison to the 20-day moving average, which settled at $127.31. In addition, Merck & Co Inc saw 16.96% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MRK starting from Merck & Co., Inc., who purchase 21,397,205 shares at the price of $23.00 back on Mar 11 ’24. After this action, Merck & Co., Inc. now owns 1,000 shares of Merck & Co Inc, valued at $492,135,715 using the latest closing price.
Davis Robert M, the Chairman, CEO & President of Merck & Co Inc, sale 85,021 shares at $125.40 during a trade that took place back on Feb 14 ’24, which means that Davis Robert M is holding 348,327 shares at $10,661,574 based on the most recent closing price.
Stock Fundamentals for MRK
Current profitability levels for the company are sitting at:
- 0.11 for the present operating margin
- 0.75 for the gross margin
The net margin for Merck & Co Inc stands at 0.04. The total capital return value is set at 0.08. Equity return is now at value 5.29, with 2.16 for asset returns.
Based on Merck & Co Inc (MRK), the company’s capital structure generated 0.46 points at debt to capital in total, while cash flow to debt ratio is standing at 0.43. The debt to equity ratio resting at 0.85. The interest coverage ratio of the stock is 7.47.
Currently, EBITDA for the company is 6.85 billion with net debt to EBITDA at 3.27. When we switch over and look at the enterprise to sales, we see a ratio of 5.72. The receivables turnover for the company is 4.89for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.25.
Conclusion
In conclusion, Merck & Co Inc (MRK) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
